Page last updated: 2024-08-16
vorinostat and pp242
vorinostat has been researched along with pp242 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Fang, Y; Qin, Y; Zhao, X | 1 |
Other Studies
1 other study(ies) available for vorinostat and pp242
| Article | Year |
|---|---|
PP242 synergizes with suberoylanilide hydroxamic acid to inhibit growth of ovarian cancer cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Proliferation; Drug Synergism; Female; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Mice; Mice, Inbred NOD; Mice, SCID; Ovarian Neoplasms; Purines; Tumor Cells, Cultured; Vorinostat; Xenograft Model Antitumor Assays | 2014 |